|
1
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vermorken JB and Specenier P: Optimal
treatment for recurrent/metastatic head and neck cancer. Ann Oncol.
21:(Suppl 7). vii252–vii261. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sawicka E, Mirończuk A, Wojtukiewicz MZ
and Sierko E: Chemoradiotherapy for locally advanced pancreatic
patients: is it still an open question? Contemp Oncol (Pozn).
20:102–108. 2016.PubMed/NCBI
|
|
4
|
van Beek TA and Montoro P: Chemical
analysis of Ginkgo biloba leaves and extracts, and
phytopharmaceuticals. J Chromatogr A. 1216:2002–2032. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Boonsai P, Phuwapraisirisan P and Chanchao
C: Antibacterial activity of a cardanol from Thai Apis mellifera
Propolis. Int J Med Sci. 11:327–336. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Meng ZL, Wei Y, Xu DM, Hao SH and Hu JY:
Effect of 2-allylphenol against Botrytis cinerea Pers., and its
residue in tomato fruit. Crop Protection. 26:1711–1715. 2007.
View Article : Google Scholar
|
|
7
|
Shi QT, Liu H, Zhang YZ, Gu S and Liu LY:
Study on antifeeding activity of ginkgo phenol to cannage
caterpillar. Biomass Chem Engineer. 43:13–16. 2009.
|
|
8
|
Trevisan MT, Pfundstein B, Haubner R,
Würtele G, Spiegelhalder B, Bartsch H and Owen RW: Characterization
of alkyl phenols in cashew (Anacardium occidentale) products and
assay of their antioxidant capacity. Food Chem Toxicol. 44:188–197.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang XM, Wang YF, Li YY and Ma HL: Thermal
stability of ginkgolic acids from Ginkgo biloba and the effects of
ginkgol C17:1 on the apoptosis and migration of SMMC7721 cells.
Fitoterapia. 98:66–76. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tan WH, Shen ZB, Wang CZ and Yu Q:
Isolation and identification of alkylphenols from Ginkgo biloba
leaves. Chem Ind Forest Prod. 21:1–6. 2001.
|
|
11
|
Lee JS, Cho YS, Park EJ, Kim JW, Oh WK,
Lee HS and Ahn JS: Phospholipase Cgamma1 inhibitory principles from
the sarcotestas of Ginkgo biloba. J Nat Prod. 61:867–871. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang YF, Yang XM, Li YY, Huang BZ, Guo CY
and Xing CH: Inhibitory effect of ginkgols on SMMC-7721 liver
cancer cells in vitro and liver cancer H22-braring mice in vivo. J
Jiangsu Univ (Med Edit). 23:233–237. 2013.
|
|
13
|
Law AY and Wong CK: Stanniocalcin-2
promotes epithelial-mesenchymal transition and invasiveness in
hypoxic human ovarian cancer cells. Exp Cell Res. 316:3425–3434.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim KH, Cho YS, Park JM, Yoon SO, Kim KW
and Chung AS: Pro-MMP-2 activation by the PPARgamma agonist,
ciglitazone, induces cell invasion through the generation of ROS
and the activation of ERK. FEBS Lett. 581:3303–3310. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Singh B, Kaur P, Gopichand Singh RD and
Ahuja PS: Biology and chemistry of Ginkgo biloba. Fitoterapia.
79:401–418. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu ZH and Zeng S: Cyctotoxicity of
ginkgolic acids in HepG2 cells and primary rat hepatocytes. Toxicol
Lett. 187:131–136. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou C, Li X, Du W, Feng Y, Kong X, Li Y,
Xiao L and Zhang P: Antitumor effects of ginkgolic acids in human
cancer cell occur via cell cycle arrest and decrease the Bcl-2/Bax
ratio to induce apoptosis. Chemotherapy. 56:393–402. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sukumari-Ramesh S, Singh N, Jensen MA,
Dhandapani KM and Vender JR: Anacardic acid induces
caspase-independent apoptosis and radiosensitizes pituitary adenoma
cells. J Neurosurg. 114:1681–1690. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wettschureck N and Offermanns S:
Rho/Rho-kinase mediated signaling in physiology and
pathophysiology. J Mol Med (Berl). 80:629–638. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kamai T, Yamanishi T, Shirataki H, Takagi
K, Asami H, Ito Y and Yoshida K: Overexpression of RhoA, Rac1, and
Cdc42 GTPases is associated with progression in testicular cancer.
Clin Cancer Res. 10:4799–4805. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Han JC, Li XD, Du J, Xu F, Wei YJ, Li HB
and Zhang YJ: Elevated matrix metalloproteinase-7 expression
promotes metastasis in human lung carcinoma. World J Surg Oncol.
13:52015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Meng F, Yang H, Jack C, Zhang H, Moller A,
Spivey D, Page RC, Tierney DL and Crowder MW: Biochemical
characterization and zinc binding group (ZBGs) inhibition studies
on the catalytic domain of MMP7 (cdMMP7). J Inorg Biochem.
165:7–17. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Simic P, Williams EO, Bell EL, Gong JJ,
Bonkowski M and Guarente L: SIRT1 suppresses the
epithelial-to-messenchymal transition in cancer and organ fibrosis.
Cell Rep. 3:1175–1186. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li KJ, Hua G and Li H: Mechanism research
progress and protection of light skin damage. J Dermatol Venereol.
32:24–27. 2010.
|
|
25
|
Guan PP, Yu X, Guo JJ, Wang Y, Wang T, Li
JY, Konstantopoulos K, Wang ZY and Wang P: By activating matrix
metalloproteinase-7, shear stress promotes chondrosarcoma cell
motility, invasion and lung colonization. Oncotarget. 6:9140–9159.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Omar A Ahmed Haji, Haglund C, Virolainen
S, Häyry V, Atula T, Kontio R, Salo T, Sorsa T and Hagström J:
MMP-7, MMP-8, and MMP-9 in oral and cutaneous squamous cell
carcinomas. Oral Surg Oral Med Oral Pathol Oral Radiol.
119:459–467. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu Y, Zhang Y, Jia K, Dong Y and Ma W:
Metformin inhibits the proliferation of A431 cells by modulating
the PI3K/Akt signaling pathway. Exp Ther Med. 9:1401–1406.
2015.PubMed/NCBI
|
|
28
|
Itoh N, Semba S, Ito M, Takeda H, Kawata S
and Yamakawa M: Phosphorylation of Akt/PKB is required for
suppression of cancer cell apoptosis and tumor progression in human
colorectal carcinoma. Cancer. 94:3127–3134. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Meuillet EJ: Novel Inhibitors of AKT:
Assessment of a different approach targeting the pleckstrin
homology domain. Curr Med Chem. 18:2727–2742. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xia S, Feng Z, Qi X, Yin Y, Jin J, Wu Y,
Wu H, Feng Y and Tao M: Clinical implication of Sox9 and activated
Akt expression in pancreatic ductal adenocarcinoma. Med Oncol.
32:3582015. View Article : Google Scholar : PubMed/NCBI
|
